Mankind Pharma Limited (BOM:543904)
2,195.65
+52.05 (2.43%)
At close: Apr 21, 2026
-14.98% (1Y)
| Market Cap | 908.22B -10.2% |
| Revenue (ttm) | 139.14B +19.5% |
| Net Income | 17.79B -12.8% |
| EPS | 43.10 -15.2% |
| Shares Out | n/a |
| PE Ratio | 51.04 |
| Forward PE | 39.25 |
| Dividend | 1.00 (0.05%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 5,304 |
| Average Volume | 42,878 |
| Open | 2,160.55 |
| Previous Close | 2,143.60 |
| Day's Range | 2,144.95 - 2,206.40 |
| 52-Week Range | 1,909.90 - 2,726.75 |
| Beta | n/a |
| RSI | 64.40 |
| Earnings Date | May 22, 2026 |